The European Medicines Agency is expected to approve the coronavirus vaccine developed by Pfizer and BioNTech on December 23rd, Reuters reported on Tuesday, citing a German government source.

The European Medicines Agency is expected to approve the coronavirus vaccine developed by Pfizer and BioNTech on December 23rd, Reuters reported on Tuesday, citing a German government source.
Tags Eurozone
The U.S.-Japan trade deal, finalized in July 2025, has reshaped global economic dynamics, impacting Eurozone …